Antibody responses to Simian Virus 40 T antigen: A case-control study of non-Hodgkin lymphoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 2, 2005, Pages 521-524

  Engels, Eric A ^a   Chen, Jinbo ^a   Hartge, Patricia ^a   Cerhan, James R ^b   Davis, Scott ^c   Severson, Richard K ^d   Cozen, Wendy ^e   Viscidi, Raphael P ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Mayo Clinic   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS T ANTIGEN;

ADULT; AGED; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BK VIRUS; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS REACTION; DNA DETERMINATION; ENZYME IMMUNOASSAY; HAMSTER; HUMAN; MACACA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; UNITED STATES; VIRUS CAPSID;

ADULT; AGED; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL, TUMOR; BK VIRUS; CAPSID PROTEINS; CASE-CONTROL STUDIES; CRICETINAE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MACACA; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 13944265580     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0441     Document Type: Article

References (25)

1. Diamandopoulos GT. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 1972;176:173-5.
2. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002;359:851-2.
3. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:817-23.
4. Anonymous. Immunization safety review. SV40 contamination of polio vaccine and cancer. Washington, DC: National Academy Press; 2003.
5. Capello D, Rossi D, Gaudino G, Carbone A, Gaidano G. Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003;361:88-9.
6. MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J Natl Cancer Inst 2003;95:1001-3.
7. Engels EA, Viscidi RP, Galloway DA, et al. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst 2004;96:1368-74.
8. Viscidi RP, Rollison DEM, Viscidi E, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003;10:278-85.
9. de Sanjose S, Shah KV, Domingo-Domenech E, et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003;104:522-4.
10. Shah KV, Galloway DA, Knowles WA, Viscidi RP. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev Med Virol 2004;14:231-9.
11. Black PH, Rowe WP, Turner HC, Huebner RJ. A specific complement-fixing antigen present in SV40 tumor and transformed cells. Proc Nat Acad Sci U S A 1963;50:1148-56.
12. Pope JH, Rowe WP. Detection of specific antigen in SV40-transformed cells by immunofluorescence. J Exp Med 1964;120:121-8.
13. Rapp F, Butel JS, Melnick JL. Virus-induced intranuclear antigen in cells transformed by papovavirus SV40. Proc Soc Exp Biol Med 1964;116:1131-5.
14. White JE. A two-stage design for the study of the relationship between a rare exposure and a rare disease. Am J Epidemiol 1982;115:119-28.
15. Lanford RE. Expression of simian virus 40 T antigen in insect cells using a baculovirus expression vector. Virology 1988;167:72-81.
16. Breslow NE, Holubkov R. Maximum likelihood estimation of logistic regression parameters under two-phase, outcome-dependent sampling. J R Stat Soc (Series B, Methodological) 1997;59:447-61.
17. Shah KV. Investigation of human malignant tumors in India for simian virus 40 etiology. J Natl Cancer Inst 1969;42:139-45.
18. Rizzo P, Carbone M, Fisher SG, et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 1999;116:470-3S.
19. David H, Mendoza S, Konishi T, Miller CW. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001;162:57-64.
20. Nakatsuka S, Liu A, Dong Z, et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003;63:7606-8.
21. Martini F, Dolcetti R, Gloghini A, et al. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 1998;78:669-74.
22. Engels EA, Katki HA, Nielsen NM, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003;95:532-9.
23. Shah KV, Daniel RW, Strickler HD, Goedert JJ. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis 1997;176:1618-21.
24. Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 2000;66:238-45.
25. Shah KV, Daniel RW, Murphy G. Antibodies reacting to simian virus 40 T antigen in human sera. J Natl Cancer Inst 1973;51:687-90.